| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/03/2004 | US20040106669 inhibitor against type-X sPLA2 (secretary PLA2) as an active ingredient |
| 06/03/2004 | US20040106668 Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin |
| 06/03/2004 | US20040106667 novel specific indazoles exhibiting anticancer activity via the modulation of the activity of proteins, in particular of kinases |
| 06/03/2004 | US20040106666 Hydroxamic acid or n-formyl hydroxylamine derivatives as inhibitors of bakterial polypeptide deformylase for treating microbial infections |
| 06/03/2004 | US20040106664 11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 06/03/2004 | US20040106663 Inhibitors of fungal invasion |
| 06/03/2004 | US20040106662 Use of the disorazoles and their derivatives for the treatment of benign and malignant oncoses |
| 06/03/2004 | US20040106661 Broadspecturm 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 06/03/2004 | US20040106660 Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| 06/03/2004 | US20040106659 hydantoin, oxazoledione and thiazoledione (or dithiione) derivatives; e.g., 5-[1-(Biphenyl-4-yloxy)-ethyl]-5-methyl-imidazolidine-2,4-dione |
| 06/03/2004 | US20040106658 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides(III) |
| 06/03/2004 | US20040106657 Indolyl derivatives |
| 06/03/2004 | US20040106656 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/03/2004 | US20040106654 Inhibitors of copper-containing amine oxidases |
| 06/03/2004 | US20040106652 such as (2S)-3,3-dimethyl-1-[2-(5-phenylpentanoyl) pyrrolidinyl]pentane-1,2-dione which has affinity for immunophilin; for treatment of neurological disorders/neurodegenerative diseases; nerve growth factors; FK binding proteins |
| 06/03/2004 | US20040106650 4-Pyrrolidino-phenyl-benzyl ether derivatives |
| 06/03/2004 | US20040106649 comprises insulin sensitizer such as 4-[4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]benzyl]isoxazolidin-3,5-dione; low toxicity |
| 06/03/2004 | US20040106647 Modulators of Cdk9 as a therapeutic target in cardiac hypertrophy |
| 06/03/2004 | US20040106646 Visual function disorder improving agents |
| 06/03/2004 | US20040106645 Antagonists of melanin concentrating hormone receptor |
| 06/03/2004 | US20040106644 Composition for treatment of night sight problems(halos, comas and glare) after refractive surgery, intra ocular lens implant after lensectomy or intraocular implant in phakic patients comprising aceclidine employed at low concentrations |
| 06/03/2004 | US20040106643 e.g., (1S,2R,3R,5R)-3-(3,4-Dichlorophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylic acid ethyl ester; |
| 06/03/2004 | US20040106642 Polysubstituted imidazopyridines as gastric secretion inhibitors |
| 06/03/2004 | US20040106641 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 06/03/2004 | US20040106640 Aryl ether substituted imidazoquinolines |
| 06/03/2004 | US20040106638 Sulfonamide and sulfamide substituted imidazoquinolines |
| 06/03/2004 | US20040106637 detecting the presence or absence of increased S6 kinase activity in said biological sample. |
| 06/03/2004 | US20040106634 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| 06/03/2004 | US20040106633 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 06/03/2004 | US20040106632 5-(4-{2-'(6-methoxy-pyrimidin-4-yl)methyl-amino)-ethoxy}-benzyl)-thiazolidin-2,4-dione sodium salt |
| 06/03/2004 | US20040106628 CX3CR1 receptor antagonists useful in the treatment or prophylaxis of neurodegenerative disorders, demyelinating disease and pain |
| 06/03/2004 | US20040106627 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors |
| 06/03/2004 | US20040106626 amidine containing compounds which inhibit serine proteases |
| 06/03/2004 | US20040106625 Therapeutic agents useful for treating pain |
| 06/03/2004 | US20040106623 For treating hypertension, Raynaud's disease and urinary incontinence |
| 06/03/2004 | US20040106622 Aryl-substituted alicylic compound and medical composition comprising the same |
| 06/03/2004 | US20040106619 For prevention and/or treatment for HIV infection or AIDS induced by the infection |
| 06/03/2004 | US20040106617 Chemical stability of levosimendan solutions can be significantly improved if the pH of the solution is lowered from neutral to lower than 5, preferably to 4.5 or lower, most preferably to 3-4.2 |
| 06/03/2004 | US20040106616 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 06/03/2004 | US20040106614 Useful for the treatment of psychiatric and neurological disorders, as well as other diseases involving cannabinoid-CB1 neurotransmission |
| 06/03/2004 | US20040106613 For treating sickle cell disease and glaucoma. |
| 06/03/2004 | US20040106610 Antagonize pharmacological actions of the endogenous neuropeptide tachykinins known as neurokinins |
| 06/03/2004 | US20040106609 Pyranoindazoles and their use for the treatment of glaucoma |
| 06/03/2004 | US20040106608 Novel imidazole compounds as transforming growth factor (TGF) inhibitors |
| 06/03/2004 | US20040106606 Dihydropyrones with tethered heterocycles |
| 06/03/2004 | US20040106605 Synergistic methods and compositions for treating cancer |
| 06/03/2004 | US20040106604 Novel pyrrole derivatives as pharmaceutical agents |
| 06/03/2004 | US20040106602 Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepines |
| 06/03/2004 | US20040106601 Method of increasing neutrophil production using optically-pure (R)-2,3-benzodiazepines |
| 06/03/2004 | US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent |
| 06/03/2004 | US20040106598 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting Beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 06/03/2004 | US20040106597 Novel fused indazoles and indoles and their use for the treatment of glaucoma |
| 06/03/2004 | US20040106596 Pyridoquinoxaline antivirals |
| 06/03/2004 | US20040106595 2H-1-benzopyran derivatives processes for their preparation and pharmaceutical compositions thereof |
| 06/03/2004 | US20040106592 Chelation of charged and uncharged molecules with porphyrin-based compounds |
| 06/03/2004 | US20040106591 Compositions and methods for the treatment of HIV-associated fat maldistribution and hyperlipidemia |
| 06/03/2004 | US20040106590 Methods and reagents for treating infections of clostridium difficile and diseases associated therewith |
| 06/03/2004 | US20040106589 Fatty acid-pharmaceutical agent conjugates |
| 06/03/2004 | US20040106588 Topical application of alpha-DFMO and steroid to treat Vulvar Intraepithelial Neoplasia |
| 06/03/2004 | US20040106587 Regulating TGF- beta expression in ovarian epithelium and/or capable of optimally altering expression of other surrogate biomarkers identified by microarray technology |
| 06/03/2004 | US20040106586 Hormone replacement therapy method and its administration form |
| 06/03/2004 | US20040106584 commonly associated with atherosclerotic cardiovascular disease, coronary disease or cerebrovascular disease. |
| 06/03/2004 | US20040106583 Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity |
| 06/03/2004 | US20040106582 carbo-or heterocycle-ethynyl-substituted pyridines or pyrimidines; e.g., 2-[2-(pyridine-3-yl)ethynyl]-6-methyl-pyridine |
| 06/03/2004 | US20040106580 Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
| 06/03/2004 | US20040106579 Mitochondrially targeted antioxidants |
| 06/03/2004 | US20040106577 decreases cerebral edema degree and other symptoms of the nerve behavior caused by cerebral ischemia and re-infusion. |
| 06/03/2004 | US20040106576 Derivatives of venlafaxine and methods of preparing and using the same |
| 06/03/2004 | US20040106575 2-Alkylated-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
| 06/03/2004 | US20040106574 4-substituted with a imidazo[1,2a]pyrid-3-yl or pyrazolo[2,3a]pyrid-3-yl ring |
| 06/03/2004 | US20040106573 Stable granulates containing s-adenosylmethionine and process for the preparation thereof |
| 06/03/2004 | US20040106572 Use of an adenosine a3 receptor agonist for inhibition of viral replication |
| 06/03/2004 | US20040106568 Nucleic acid sequences containing unmethylated CpG dinucleotides that modulate an immune response including stimulating a Th1 pattern of immune activation, cytokine production, NK lytic activity, and B cell proliferation |
| 06/03/2004 | US20040106567 inhibiting expression of a gene in an extravascular mammalian cell by: a) injecting a naked polynucleotide into a blood vessel lumen; b) increasing permeability in the vessel; and, c) delivering the polynucleotide to an extravascular cell |
| 06/03/2004 | US20040106563 For use against vascular diesases or graft rejection. |
| 06/03/2004 | US20040106562 Drugs containing reduced of vitamin b2 |
| 06/03/2004 | US20040106561 comprises phytoestrogen isolated from red clover or soya, selected from genistein, daidzein, biochanin A, and/or formononetin; for treatment/prevention of cancer |
| 06/03/2004 | US20040106560 such as N1-L-Arginylspermidine for protecting from damage from extended ischemic/hypoxic events |
| 06/03/2004 | US20040106559 for inhibiting proteases |
| 06/03/2004 | US20040106554 polypeptide analogs of myelin basic protein for treatment of multiple sclerosis |
| 06/03/2004 | US20040106553 Methods for preventing and treating microbial infections by modulating transcription factors |
| 06/03/2004 | US20040106546 comprises cyclosporin, hyaluronic acid, and polysorbate compound |
| 06/03/2004 | US20040106544 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane associating elements |
| 06/03/2004 | US20040106542 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 06/03/2004 | US20040106540 Method of treating cancer |
| 06/03/2004 | US20040106539 Agents for the treatment of viral infections |
| 06/03/2004 | US20040106538 Regulators of PPARdelta (beta) and their use in the treatment of obesity and insulin resistance |
| 06/03/2004 | US20040106537 treating inflammatory skin, pulmonary, musculoskeletal, and gastrointestinal diseases, autoimmune disorders, transplantation treatment, and osteoporosis |
| 06/03/2004 | US20040106196 Systems and methods for treating patients with processed lipoaspirate cells |
| 06/03/2004 | US20040106185 Oral bacteriotherapy compositions and methods |
| 06/03/2004 | US20040106181 Novel isoform of human camp-dependent protein kinase, calpha -s , localizes to sperm mid-piece and the use thereof |
| 06/03/2004 | US20040106124 Identifying genotype for depressive episodes and modifying administration of antidepressants and adrenergic stimulants |
| 06/03/2004 | US20040105943 Multiplayer electrometric material containing active chemical substance, and uses thereof |
| 06/03/2004 | US20040105907 Anti-inflammatory effects of the partially purified extract of radix stephaniae tetrandrae |
| 06/03/2004 | US20040105906 Antiagionecic, antitumor, chemopreventative agents |
| 06/03/2004 | US20040105905 Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium) |
| 06/03/2004 | US20040105897 matrix metalloproteinases (MMPs) useful for treating chronic wounds |
| 06/03/2004 | US20040105894 Trace Metals synergized copper nucleotides and copper glycosides for anti-aging and antiviral compositions |
| 06/03/2004 | US20040105891 Modafinil formulations |
| 06/03/2004 | US20040105889 comprising nanoparticulate active agents and stabilizers; particularly useful for patients who cannot swallow or who have difficulty swallowing |